1. Chronic myeloid leukemia‐derived extracellular vesicles increase Foxp3 level and suppressive activity of thymic regulatory T cells
- Author
-
Ewa Kozlowska, Wioleta Dudka, Marta Brewińska-Olchowik, Katarzyna Piwocka, Lukasz Bugajski, and Julian Swatler
- Subjects
0301 basic medicine ,Blast Crisis ,medicine.medical_treatment ,Immunology ,Thymus Gland ,Biology ,Lymphocyte Activation ,T-Lymphocytes, Regulatory ,Extracellular vesicles ,regulatory T cells ,Extracellular Vesicles ,03 medical and health sciences ,0302 clinical medicine ,chronic myeloid leukemia ,Leukemia, Myelogenous, Chronic, BCR-ABL Positive ,hemic and lymphatic diseases ,Immune Tolerance ,medicine ,Humans ,Immunology and Allergy ,Letter to the Editor ,Transcription factor ,Cells, Cultured ,immunosuppression ,Gene Expression Regulation, Leukemic ,FOXP3 ,Myeloid leukemia ,Forkhead Transcription Factors ,Immunosuppression ,Up-Regulation ,030104 developmental biology ,medicine.anatomical_structure ,Foxp3 ,Neoplastic Stem Cells ,Cancer research ,Bone marrow ,Function (biology) ,030215 immunology - Abstract
Mechanisms driving immunosuppression in chronic myeloid leukemia are mostly unknown. We show that leukemic extracellular vesicles (EVs) target lymphocytes and amplify suppressive function of thymic regulatory T cells, by driving expression of Foxp3 transcription factor. This could facilitate expansion of leukemic cells outside the bone marrow, leading to blast crisis.
- Published
- 2019
- Full Text
- View/download PDF